Bruce Rutherford
Direktor/Vorstandsmitglied bei Dentigenix, Inc.
Profil
Bruce Rutherford is currently a Director at Dentigenix, Inc. He was previously a Vice President-Clinical Development at Novalar Pharmaceuticals, Inc. and a Chief Scientific Officer at Dentigenix, Inc. Rutherford holds a doctorate degree from the University of Rochester and an undergraduate degree from the University of Washington.
Aktive Positionen von Bruce Rutherford
| Unternehmen | Position | Beginn |
|---|---|---|
Dentigenix, Inc.
 Dentigenix, Inc. BiotechnologyHealth Technology Dentigenix, Inc. develops tissue engineering, stem cell, and dental biological products. The company was founded by Christopher P. Somogyi on January 21, 2003 and is headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Bruce Rutherford
| Unternehmen | Position | Ende |
|---|---|---|
Dentigenix, Inc.
Dentigenix, Inc. BiotechnologyHealth Technology Dentigenix, Inc. develops tissue engineering, stem cell, and dental biological products. The company was founded by Christopher P. Somogyi on January 21, 2003 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Novalar Pharmaceuticals, Inc.
 Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Ausbildung von Bruce Rutherford
| University of Washington | Undergraduate Degree |
| Rochester Christian University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Novalar Pharmaceuticals, Inc.
Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA. | Health Technology |
Dentigenix, Inc.
Dentigenix, Inc. BiotechnologyHealth Technology Dentigenix, Inc. develops tissue engineering, stem cell, and dental biological products. The company was founded by Christopher P. Somogyi on January 21, 2003 and is headquartered in Seattle, WA. | Health Technology |